Long-term therapeutic plasma exchange in the outpatient setting using an implantable central venous access device
| Autor: | Janice Flanagan, Donata Sodano, Cindy Ouillette, Anneliese Gonzalez, Robert Weinstein |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
Catheterization Central Venous Clinical Trials as Topic medicine.medical_specialty Time Factors Plasma Exchange business.industry Hematology General Medicine Middle Aged Surgery Venous access Plasma flow Catheter Apheresis Ambulatory Blood Component Removal Outpatient setting Humans Medicine Therapeutic plasma exchange business Adverse effect Aged Follow-Up Studies |
| Zdroj: | Journal of Clinical Apheresis. 19:180-184 |
| ISSN: | 1098-1101 0733-2459 |
| DOI: | 10.1002/jca.20024 |
| Popis: | We presented the results of our prospective trial of the Bard CathLink® 20 in outpatient therapeutic plasma exchange in May 2000. Since the close of that study, three of the original subjects and one additional subject have received continuous outpatient treatment using the device. We report herein on its long-term use. Four patients with demyelinating polyneuropathy underwent outpatient plasma exchange of 1–1¼ plasma volumes using Bard CathLink® 20 venous access devices for up to 2½ years. Treatment schedules varied according to the status of the patient's neuropathy. Four men (age 59, 60, 76, 79) underwent 55, 56, 38, and 41 plasma exchanges over 18.5, 18, 20, and 38.5 months, respectively, all in the outpatient setting. Ninety-one percent were completed in |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text